Nav: Home

Scientists discover novel process to convert visible light into infrared light

January 16, 2019

Columbia University scientists, in collaboration with researchers from Harvard, have succeeded in developing a chemical process to convert infrared energy into visible light, allowing innocuous radiation to penetrate living tissue and other materials without the damage caused by high-intensity light exposure.

Their research is published in the January 17 issue of Nature.

"The findings are exciting because we were able to perform a series of complex chemical transformations that usually require high-energy, visible light using a noninvasive, infrared light source," said Tomislav Rovis, professor of chemistry at Columbia and co-author of the study. "One can imagine many potential applications where barriers are in the way to controlling matter. For example, the research holds promise for enhancing the reach and effectiveness of photodynamic therapy, whose full potential for managing cancer has yet to be realized."

The team, which includes Luis M. Campos, associate professor of chemistry at Columbia, and Daniel M. Congreve of the Rowland Institute at Harvard, carried out a series of experiments using small quantities of a novel compound that, when stimulated by light, can mediate the transfer of electrons between molecules that otherwise would react more slowly or not at all.

Their approach, known as triplet fusion upconversion, involves a chain of processes that essentially fuses two infrared photons into a single visible light photon. Most technologies only capture visible light, meaning the rest of the solar spectrum goes to waste. Triplet fusion upconversion can harvest low-energy infrared light and convert it to light that is then absorbed by the solar panels. Visible light is also easily reflected by many surfaces, whereas infrared light has longer wavelengths that can penetrate dense materials.

"With this technology, we were able to fine-tune infrared light to the necessary, longer wavelengths that allowed us to noninvasively pass through a wide range of barriers, such as paper, plastic molds, blood and tissue," Campos said. The researchers even pulsed light through two strips of bacon wrapped around a flask

Scientists have long tried to solve the problem of how to get visible light to penetrate skin and blood without damaging internal organs or healthy tissue. Photodynamic therapy (PDT), used to treat some cancers, employs a special drug, called a photosensitizer, that is triggered by light to produce a highly reactive form of oxygen that is able to kill or inhibit the growth of cancer cells.

Current photodynamic therapy is limited to the treatment of localized or surface cancers. "This new technology could bring PDT into areas of the body that were previously inaccessible," Rovis said.

"Rather than poisoning the entire body with a drug that causes the death of malignant cells and healthy cells, a nontoxic drug combined with infrared light could selectively target the tumor site and irradiate cancer cells."

The technology could have far-reaching impact. Infrared light therapy may be instrumental in treating a number of diseases and conditions, including traumatic brain injury, damaged nerves and spinal cords, hearing loss, as well as cancer.

Other potential applications include remote management of chemical storage solar power production and data storage, drug development, sensors, food safety methods, moldable bone-mimic composites and processing microelectronic components.

The researchers are currently testing photon-upconversion technologies in additional biological systems. "This opens up unprecedented opportunities to change the way light interacts with living organisms," Campos said. "In fact, right now we are employing upconversion techniques for tissue engineering and drug delivery."
-end-


Columbia University

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.